| Affibody molecules: engineered proteins for therapeutic, diagnostic and biotechnological applications J Löfblom, J Feldwisch, V Tolmachev, J Carlsson, S Ståhl, FY Frejd FEBS letters 584 (12), 2670-2680, 2010 | 756 | 2010 |
| Enhancement of the antitumor activity of interleukin-12 by targeted delivery to neovasculature C Halin, S Rondini, F Nilsson, A Berndt, H Kosmehl, L Zardi, D Neri Nature biotechnology 20 (3), 264-269, 2002 | 332 | 2002 |
| Affibody molecules in biotechnological and medical applications S Ståhl, T Gräslund, AE Karlström, FY Frejd, PÅ Nygren, J Löfblom Trends in biotechnology 35 (8), 691-712, 2017 | 330 | 2017 |
| Targeted delivery of tissue factor to the ED-B domain of fibronectin, a marker of angiogenesis, mediates the infarction of solid tumors in mice F Nilsson, H Kosmehl, L Zardi, D Neri Cancer research 61 (2), 711-716, 2001 | 315 | 2001 |
| Affibody molecules as engineered protein drugs FY Frejd, KT Kim Experimental & molecular medicine 49 (3), e306-e306, 2017 | 207 | 2017 |
| Non-immunoglobulin based protein scaffolds J Löfblom, FY Frejd, S Ståhl Current opinion in biotechnology 22 (6), 843-848, 2011 | 179 | 2011 |
| Lockscreen display F Nilsson US Patent App. 12/472,570, 2010 | 177 | 2010 |
| Phage display selection of Affibody molecules with specific binding to the extracellular domain of the epidermal growth factor receptor M Friedman, E Nordberg, I Höidén-Guthenberg, H Brismar, GP Adams, ... Protein engineering, design & selection 20 (4), 189-199, 2007 | 171 | 2007 |
| [29] Design and use of phage display libraries for the selection of antibodies and enzymes F Viti, F Nilsson, S Demartis, A Huber, D Neri Methods in enzymology 326, 480-505, 2000 | 168 | 2000 |
| The use of phage display for the development of tumour targeting agents F Nilsson, L Tarli, F Viti, D Neri Advanced drug delivery reviews 43 (2-3), 165-196, 2000 | 157 | 2000 |
| Affibody molecules for epidermal growth factor receptor targeting in vivo: aspects of dimerization and labeling chemistry V Tolmachev, M Friedman, M Sandström, TLJ Eriksson, D Rosik, M Hodik, ... Journal of Nuclear Medicine 50 (2), 274-283, 2009 | 146 | 2009 |
| Same-day imaging using small proteins: clinical experience and translational prospects in oncology A Krasniqi, M D’Huyvetter, N Devoogdt, FY Frejd, J Sörensen, A Orlova, ... Journal of Nuclear Medicine 59 (6), 885-891, 2018 | 124 | 2018 |
| Cellular studies of binding, internalization and retention of a radiolabeled EGFR-binding affibody molecule E Nordberg, M Friedman, L Göstring, GP Adams, H Brismar, FY Nilsson, ... Nuclear medicine and biology 34 (6), 609-618, 2007 | 103 | 2007 |
| In vivo imaging of the programmed death ligand 1 by 18F PET DEG Trotter, X Meng, P McQuade, D Rubins, M Klimas, Z Zeng, ... Journal of Nuclear Medicine 58 (11), 1852-1857, 2017 | 100 | 2017 |
| Site-specific radiometal labeling and improved biodistribution using ABY-027, a novel HER2-targeting Affibody molecule–albumin-binding domain fusion protein A Orlova, A Jonsson, D Rosik, H Lundqvist, M Lindborg, L Abrahmsen, ... Journal of Nuclear Medicine 54 (6), 961-968, 2013 | 97 | 2013 |
| Combining phage and staphylococcal surface display for generation of ErbB3-specific Affibody molecules N Kronqvist, M Malm, L Göstring, E Gunneriusson, M Nilsson, ... Protein Engineering, Design & Selection 24 (4), 385-396, 2011 | 91 | 2011 |
| Engineering and characterization of a bispecific HER2× EGFR‐binding affibody molecule M Friedman, S Lindström, L Ekerljung, H Andersson‐Svahn, J Carlsson, ... Biotechnology and applied biochemistry 54 (2), 121-131, 2009 | 86 | 2009 |
| Engineered high-affinity affibody molecules targeting platelet-derived growth factor receptor β in vivo M Lindborg, E Cortez, I Höidén-Guthenberg, E Gunneriusson, ... Journal of molecular biology 407 (2), 298-315, 2011 | 82 | 2011 |
| Inhibiting HER3-mediated tumor cell growth with affibody molecules engineered to low picomolar affinity by position-directed error-prone PCR-like diversification M Malm, N Kronqvist, H Lindberg, L Gudmundsdotter, T Bass, FY Frejd, ... Plos one 8 (5), e62791, 2013 | 81 | 2013 |
| Compositions and methods for treatment of angiogenesis in pathological lesions L Zardi, D Neri, B Carnemolla, F Nilsson, L Tarli, L Borsi, C Halin | 76 | 2001 |
Vladimir TolmachevProfessor of biomedical radiation sciences, Uppsala UniversityVerified email at igp.uu.se
